Ultragenyx Pharmaceutical | RARE - Les Intérêts Débiteurs Sur La Dette





Les Intérêts Débiteurs Sur La Dette Changement Date
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Agios Pharmaceuticals USD 1.18B 4.3B 2026-03
Alnylam Pharmaceuticals USD 69.29M 60.05M 2026-03
BioCryst Pharmaceuticals USD 14.14M 5.53M 2025-12
BioMarin Pharmaceutical USD 14.96M 12.18M 2026-03
Esperion Therapeutics USD 22.64M 585K 2025-12
Immunic 197K 222K 2025-12
Insmed USD 20.6M 217K 2025-12
Ionis Pharmaceuticals USD 17M 1000K 2026-03
Karyopharm Therapeutics USD 12.62M 1.24M 2025-12
Kyowa Hakko Kirin JPY 435M 94M 2025-12
MacroGenics USD 3.34M 2.54M 2025-09
Moderna USD 11.49B 36B 2026-03
Neurocrine Biosciences USD 1.1M 0 2024-03
PTC Therapeutics USD 50.58M 2.59B 2025-12
Puma Biotechnology USD 3.37M 11K 2024-06
Regeneron Pharmaceuticals USD 12.9M 700K 2026-03
Sarepta Therapeutics USD 7.56M 2.33M 2025-09
Ultragenyx Pharmaceutical USD 19M 4.85M 2025-12
Vertex Pharmaceuticals USD 3.3M 0 2025-12
Xoma USD 3.4M 150K 2024-06